KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to -$4.9 million.

  • Medpace Holdings' Change in Receivables fell 14711.18% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.8 million, marking a year-over-year increase of 18111.36%. This contributed to the annual value of -$2.2 million for FY2024, which is 10464.36% down from last year.
  • Medpace Holdings' Change in Receivables amounted to -$4.9 million in Q3 2025, which was down 14711.18% from $79.9 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Change in Receivables registered a high of $79.9 million during Q2 2025, and its lowest value of -$19.1 million during Q1 2024.
  • For the 5-year period, Medpace Holdings' Change in Receivables averaged around $11.3 million, with its median value being $4.5 million (2022).
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 710312.5% in 2022, then crashed by 54005.52% in 2024.
  • Over the past 5 years, Medpace Holdings' Change in Receivables (Quarter) stood at -$64000.0 in 2021, then soared by 7103.12% to $4.5 million in 2022, then surged by 100.09% to $9.0 million in 2023, then tumbled by 270.32% to -$15.3 million in 2024, then skyrocketed by 68.17% to -$4.9 million in 2025.
  • Its Change in Receivables stands at -$4.9 million for Q3 2025, versus $79.9 million for Q2 2025 and $2.1 million for Q1 2025.